A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy

Clinical trial NCT01556776 · COMPLETED

Trial details

NCT number: NCT01556776
Sponsor: German CLL Study Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2012-07-20
Primary completion: 2016-03-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.